€200Mln Pharma and CDMO investment (2015) by Sanofi for Insulin at Industriepark Höchst in Germany
About this project
Pharma and CDMO investment of € 200 mln by Sanofi at Industriepark Höchst in Germany, Europe, targeting the production of Insulin.
Investment details
Detailed data on 1100+ projects in Europe